0 Comments
The Global Musculoskeletal System Disorders Market is projected to register a CAGR of 5.3% to reach an estimated USD 5.73 billion by 2025. The growth of global musculoskeletal system disorders market is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are expected to curb the growth of the global musculoskeletal system disorders market.
The rising number of cases of work-related musculoskeletal system disorders in developing nations and an increase in the geriatric population in developed nations are driving the growth of the market. Musculoskeletal System Disorders Market Key Players: Some of the key players in the global musculoskeletal system disorders market are
Americas: The largest regional market.
https://www.marketresearchfuture.com/reports/musculoskeletal-system-disorders-market-8232 Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ Medical Marijuana Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Medical Marijuana Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Industry Synopsis: Global Medical Marijuana Market is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions. Marijuana consists of chemical components cannabinoids, which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy. The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period. Top Players: The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies. Segmentation: The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel. On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD). The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice. The market, by distribution channel, has been segmented into dispensaries and online platforms. Industry Updates: In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019. In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes. In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more. Medical Marijuana Market - Regional Analysis: The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies. Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ According to Latest study of MRFR, Biosensors Market Development and Demand Forecast to 2020 On Path to Achieve A CAGR of 9.6 % and set to profit from Surge in Healthcare Industry Development.
Analysis The increased integration of technology in healthcare is promoting the use of Biosensorss favorably. Reports that appraise the healthcare industry have been presented by Market Research Future, which creates reports on industry verticals that assess the Biosensor market development and projections. The market is anticipated to perceive a CAGR of 9.6 % approximately from 2014 to 2020. Table of Content Chapter 3. Market Outlook 3.1 Introduction 3.2 Trends in the Market 3.2.1 Rising product innovation 3.2.2 Technological advancement of Biosensorss leading to miniaturizations of sensors 3.3 Opportunities in the Market 3.3.1 Opportunity from increasing demand of personalized medicine 3.4 Factors Driving the Market and its Impact on Market Forecast 3.4.1 Rising aging population 3.4.2 Increasing diabetic population 3.4.3 Rising prevalence of chronic and lifestyle induced disease 3.4.4 Increasing demand for POCT 3.4.5 Increasing application of Biosensorss in various industries 3.4.6 Impact analysis of drivers on market forecast 3.5 Factors Hindering the Market and its Impact on Market Forecast 3.5.1 Strict regulatory requirements 3.5.2 Reimbursement policies issues in healthcare systems 3.5.3 Impact analysis of restraints on market forecast Continued…. Biosensors market Segmentation: By technology, the market divides into thermal Biosensorss, electrochemical Biosensorss, piezoelectric Biosensorss, optical Biosensorss, and others. The piezoelectric Biosensorss hold the largest share in this market segment. By application, the market includes industrial process, agricultural testing, medical testing, environmental market, into food toxicity, and others. By end-user, the market comprises research laboratories, security and biodefense, food industry, point of care, home diagnostics, and others. The security and biodefence segment is the biggest market share holder because of the increasing biological threats and the proliferating need to protect them. Collect detailed information of Biosensors Market segmented by technology by end user, by application (medical testing, food toxicity, industrial process, environmental market, agricultural testing, others) - Forecast to 2020 @ https://www.marketresearchfuture.com/reports/Biosensors-market-1228 Competitive Landscape The global Biosensors market holds a number of key players including Nova Biomedical Corporation, F. Hoffmann-La Roche Ltd., TiaDoc Technology Corporation, LifeSensors Inc., Medtronic, Inc., Siemens Healthcare, Abbott Laboratories Inc., I-SENCE Inc., Johnson & Johnson, and Bayer Healthcare. Browse other healthcare Related Reports Insulin Delivery Devices Market Non-Invasive Prenatal Testing Market About Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services Contact: https://www.marketresearchfuture.com/ Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report - Global Forecast till 2025. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.
According to MRFR analysis, the global Non-Invasive Prenatal Testing Market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018. Non-Invasive Prenatal Testing (NIPT) Market Overview NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births. The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders. Segmentation The global NIPT market has been segmented based on product type, techniques, application, and end user. The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others. The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection. On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others. The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing. Key Players Some of the key players in the global NIPT market are Laboratory Corporation of America Holdings (US), Natera, Inc, Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG ] (Germany), Agilent Technologies, Inc, Beijing Genomics Institute (China), General Electric Company [GE Healthcare] (US), Illumina, Inc, Perkinelmer, Inc, PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc, Thermo Fisher Scientific, Inc, and F Hoffman-La Roche Ltd. Browse full report @ https://www.marketresearchfuture.com/reports/non-invasive-prenatal-testing-market-8371 Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures. The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. Related Reports Pseudomonas Aeruginosa treatment market Behavioral Health Services Market About Us MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: Market Research Future https://www.marketresearchfuture.com/ Behavioral Health Services Market Research Report - Global Forecast till 2025
Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders. Behavioral health includes conditions such as depression, anxiety, substance abuse, and others. Around 83% people in the US are suffering from behavioral health issues. According to Japanese study around 298 people were suffering from various behavioral disorders in 2018. The growth of the global behavioral health services market is driven by various factors such as an increasing global geriatric population, rising prevalence of the depressive disorder, and poor fitness levels. However, high costs of treatment are expected to curb the growth of the global behavioral health services market. According to MRFR analysis, Behavioral Health Services Market is expected to register a CAGR of 3.4% during the forecast period of 2019 to 2025 and was valued at USD 146.3 Billion by 2025. Segmentation The Global Behavioral Health Services Market has been segmented based on services type, disorder type, and end user. The market, based on services type, has been divided into inpatient hospital treatment, outpatient counseling, home-based treatment services, emergency mental health services, and others. The inpatient hospital treatment segment is likely to be the largest during the review period due to a growing aging population globally. Around 1.3 million Americans are diagnosed with various behavioral disorders every year. The outpatient counseling segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population. The global behavioral health services market has been segmented on the basis of disorder type, into anxiety disorder, bipolar disorders, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder, and others. The anxiety disorder segment is expected to hold the majority share of the market. Rising prevalence of anxiety disorder in most commonly seen in US. Around 40 million adults are diagnosed with anxiety disorder every year. The bipolar disorder segment is expected to be the fastest-growing due to its rising prevalence globally. It was estimated that around 7 million people in US were suffering through bipolar disorder in 2018. The end user segments of the market are providers, patients, and others. The providers segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and services. Key Players Some of the key players in the global Behavioral Health Services market are Acadia Healthcare (US), National Mentor Holdings Inc (US), Behavioral Health Services Inc (US), Ocean Mental Health Services Inc (US), The MENTOR Network (US), Universal Health Services, Inc (US), Behavioral Health Network, Inc (US), CareTech Holdings PLC (UK), Strategic Behavioral Health (US), North Range Behavioral Health (US), Pyramid Healthcare (US), Promises Behavioral Health (US), and others. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of behavioral disorders and rising per capita healthcare expenditure. The behavioral health services market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European behavioral health services market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The behavioral health services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of depression disorder and raising awareness about the behavioral health services methods, the market in Asia-Pacific is expected to be the fastest-growing. The behavioral health services market in the Middle East & Africa has been divided into the Middle East and Africa. Get full report @ https://www.marketresearchfuture.com/reports/behavioral-health-services-market-8433 Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.co Market Highlights
According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018. Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells. The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric populations is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk of side effects that can occur due to high usage of biopharmaceuticals, and stringent government regulations are expected to pose as restraints to the growth of the global biopharmaceuticals market. Key Players Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India). Segmentation The global biopharmaceuticals market has been segmented based on product type and application. The global biopharmaceuticals market has been segmented, on the basis of product type, into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, and others. The recombinant growth factors has been further bifurcated into erythropoietin and granulocyte colony-stimulating factor. The purified proteins segment has been further classified as leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment has been further divided into serum albumin, amyloid protein, defensin, transferrin, and others. Vaccines have also been segregated into recombinant vaccines, conventional vaccines, and others. The recombinant vaccines have been further sub-segmented into cancer vaccines, malaria vaccines, Ebola vaccines, hepatitis B vaccines, tetanus vaccines, diphtheria vaccines, cholera vaccines, and others. Conventional vaccines have been categorized as polio vaccines, pox vaccines, and others. Synthetic immunomodulators segment has been further divided into cytokines, interferons, interleukins, tumor necrosis factor (TNF), and others. Monoclonal antibodies segment is anticipated to hold the largest market share in the global biopharmaceutical market due to the increasing number of research activities that are supported by the usage of monoclonal antibodies. Vaccines are expected to grow at the fastest CAGR owing to the rising awareness of chronic diseases. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa. Get full report @https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439 Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ Market Research Future published a research report on Infection Control Market Research Report –Global Forecast to 2023.Report gives a clear picture of current market scenario which includes past and estimated future market size
Infection Control Market Overview The use of clinical trials for pinpointing causes of hospital acquired infections (HAIs) in hospitals is likely to affect the market demand significantly. According to the University of Michigan, close to 2 million infections occur in national hospitals. Development of infection control products as well as its subsequent adoption by hospitals can fuel the market revenue. For instance, the Surfacide Helios system which emits ultraviolet (UV-C) energy for detecting the presence of bacterial infections. Infection Control Market Segmentation: The global infection control market has been segmented on the basis of type and end-user. On the basis of type, the global infection control market can be segmented into disinfection products, sterilization products and services, and others. Disinfection products are categorized into disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors. Disinfectants are categorized into type, formulation, and EPA classification. Disinfectants by type are classified into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants. The disinfectant by formulation is categorized into disinfectant wipes, disinfectant liquids, and disinfectant sprays. The EPA classification is categorized into low-level disinfectants, intermediate-level disinfectants, and high-level disinfectants. Medical nonwovens are classified into surgical drapes, surgical gowns, sterilization wraps, and face masks. Disinfectors are classified into washer disinfectors, flusher disinfectors, and UV ray disinfectors. The endoscope reprocessors are classified into automated endoscope reprocessors, endoscope tracking systems, and other endoscopic reprocessing products. Get detailed information on Global Infection Control Market Research Report: By Type (Disinfection Products, Sterilization Products, & Services), by End-U.S.er (Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies) @ https://www.marketresearchfuture.com/reports/infection-control-market-5901 Intended Audience
Leading Market Players STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Pal Internation (U.K.), Nordion, Inc. (U.S.), Ahlstrom Corporation (Finland), Honeywell International, Inc. (U.S.), and others. Related Healthcare News Sex Cord Gonadal Stromal Tumor Market Ophthalmic Equipment Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions Contact: www.marketresearchfuture.com Market Highlights
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers. It is noted that the increasing cases of ovarian and testicular cancer, technological advancements, and increasing healthcare expenditure are the key factors driving the sex cord gonadal stromal tumor market. Various other factors such as the growing awareness about the cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement are continuously contributing to the growth of the global sex cord-gonadal stromal tumor market. Owing to the increasing cases of ovarian and testicular cancer, technological advancements, increasing healthcare expenditure, growing awareness about sex cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the sex cord-gonadal stromal tumor market has evolved significantly. However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in low and middle-income countries are likely to hamper the growth of the sex cord-gonadal stromal tumor market over the forecast period. It is estimated that the sex cord-gonadal stromal tumor market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023. Key Players Some of the key players in the global sex cord-gonadal stromal tumor market are Abbott, Abcam plc, Affymetrix, Inc., Agilent Technologies, Inc., Beckman, Dickinson and Company (BD), Bio SB Inc., BioCurex, BioModa, Inc., Bio-Rad Laboratories, Inc., Boston Scientific Corporation, Cell Signaling Technology, Inc., Clarient, Inc., CooperSurgical Inc., Correlogic Systems, Inc., Danaher Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Gen-Probe, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Karl Storz GmbH & Co. Kg, LiNA Medical USA, Merck Millipore, PerkinElmer, Inc., Qiagen, Radient Pharmaceuticals, Thermo Fisher Scientific Inc., Veridex LLC, and others. Regional Analysis The Americas dominates the sex cord-gonadal stromal tumor market owing to the increasing prevalence of ovarian cancer in this region and high healthcare expenditure. According to the American Cancer Society, around 22,240 women are likely to be diagnosed with ovarian cancer, and 14,070 women are likely to die from ovarian cancer, in 2018. Europe holds the second position in the sex cord-gonadal stromal tumor market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European sex cord-gonadal stromal tumor market. The increasing healthcare expenditure is also boosting the European sex cord-gonadal stromal tumor market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association. Asia Pacific is the fastest growing sex cord-gonadal stromal tumor market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015. The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities. Segmentation The global sex cord-gonadal stromal tumor market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of tumor type, the sex cord-gonadal stromal tumor market is classified as granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, Sertoli Leydig cell tumor, gynandroblastoma, and Sex Cord Tumor with Annular Tubules (SCTAT). The granulosa cell tumor is further classified as functioning tumors and non-functioning tumors. On the basis of diagnosis, the sex cord-gonadal stromal tumor market is classified as microscopy immunohistochemistry, tumor marker, ultrasound, Magnetic Resonance Imaging (MRI), and others. The tumor marker segment is further classified as inhibin-alpha, calretinin, Melan-A, and others. On the basis of treatment, the sex cord-gonadal stromal tumor market is classified as chemotherapy, radiotherapy, surgery, and others. The surgery segment is further classified as salpingo-oophorectomy, abdominal hysterectomy, Retroperitoneal Lymph Node Dissection (RPLND), and radical inguinal orchiectomy. The sub-segment of salpingo-oophorectomy includes unilateral salpingo-oophorectomy and bilateral salpingo-oophorectomy. On the basis of end-user, the sex cord-gonadal stromal tumor market is segmented into hospitals and clinics, cancer research centers, research and academic institutes, and others. Get full report @https://www.marketresearchfuture.com/reports/sex-cord-gonadal-stromal-tumor-market-5912 Intended Audience Medical Device Companies Research and Development (R&D) Companies Diagnostic Laboratories Government Research Institutes Academic Institutes and Universities Browse other healthcare related report Sex Cord Gonadal Stromal Tumor Market Endometrial Cancer Market About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: https://www.marketresearchfuture.com MRFR’s Outlook towards the Worldwide Ophthalmic Equipment Market Remains Positive with a 5.4 % CAGR forecast for the Next Five Years. And Provide Overview of Key Players and their Strategic Profiling in the Market, Comprehensively Analyzing their Core Competencies, and Drawing a Competitive Landscape for the Market.
Ophthalmic Equipment Market – Key Players Some of the key players in this market are Alcon (U.S.), Bausch & Lomb (U.S.), Carl Zeiss Meditec (Germany), Johnson & Johnson (U.S.), Essilor International S.A. (France), Haag-Streit (Switzerland), Nidek (Korea), Staar Surgical (U.S.), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Hoya Corporation (Japan), Ridex Corporation (U.S.), and others. Ophthalmic Equipment Market – Highlights The market in Asia Pacific is expected to grow rapidly in the coming years. Based on a detailed study and analysis, it is found that this region has a good growth potential due to the increasing unhealthy eating habits and unhygienic conditions. Major factors driving the market are increasing geriatric population and increasing healthcare expenditure. On the other hand, low awareness in developing and underdeveloped regions regarding ophthalmic diseases may hamper the market growth during the forecast period. Ophthalmic Equipment Market – Segmentation The global ophthalmic equipment market is segmented on the basis of product, application, and end-user. On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contact lenses are further segmented into soft contact lenses, Rigid Gas Permeable lenses (RGP), and hybrid contact lenses. Ophthalmology surgical devices are segmented into cataract surgical devices, vitreoretinal surgical devices, refractive surgical devices, glaucoma surgical devices, ophthalmic microscopes, ophthalmic accessories, and others. Cataract surgical devices are further segmented into Intraocular Lenses (IOLS), Ophthalmic Viscoelastic Devices (OVDS), phacoemulsification devices, cataract surgical lasers, and others. The vitreoretinal surgical devices segment is further segmented into vitreoretinal packs, vitrectomy machines, photocoagulation lasers, illumination devices, vitrectomy probes, and others. The refractive surgical devices segment is further segmented into femtosecond lasers, excimer lasers, and others. Glaucoma surgical devices are further segmented into Glaucoma Drainage Devices (GDDS), and micro-invasive glaucoma surgical devices. Ophthalmic accessories are further segmented into surgical instruments and kits, ophthalmic forceps, ophthalmic spatulas, ophthalmic tips and handles, ophthalmic scissors, macular lenses, ophthalmic cannulas, and others. Diagnostic and monitoring devices are segmented into optical coherence tomography scanners, fundus cameras, perimeters/visual field analyzers, autorefractors and keratometers, ophthalmic ultrasound imaging systems, tonometers, slit lamps, phoropters, wavefront aberrometers, optical biometry systems, ophthalmoscopes, lensmeters, corneal topography systems, chart projectors, specular microscopes, retinoscopes, and others. Ophthalmic ultrasound imaging systems are further segmented into ophthalmic A-scan ultrasound, ophthalmic b-scan ultrasound, ophthalmic ultrasound biomicroscopes, and ophthalmic pachymeters. On the basis of application, the market is segmented into glaucoma, amblyopia, cataract, retinal detachment, and others. On the basis of end-user, the market is segmented into hospitals, ophthalmology clinics, diagnostic centers, research centers, and others. Ophthalmic Equipment Market – Regional Analysis The Americas dominates the global ophthalmic equipment market owing to the increasing prevalence of ophthalmic diseases and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth. Europe is the second largest in the global ophthalmic equipment market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region. Asia Pacific is estimated to be the fastest growing market for ophthalmic equipment. This can be attributed to the presence of developing economies such as India and China and a huge patient population suffering from ophthalmic diseases. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region. On the other hand, the Middle East and Africa has the least share in the global ophthalmic equipment market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region. Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/ophthalmic-equipment-market-5973 Related Healthcare News Telemedicine Market Infection Control Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions Contact: www.marketresearchfuture.com |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |